Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-30 4:35 pm Purchase | 2025-04-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Venrock Healthcare Capital Partners III, L.P. | 6,596,885 7.700% | 3,414,358 (+107.28%) | Filing |
| 2025-05-15 5:47 pm Sale | 2025-03-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Venrock Healthcare Capital Partners III, L.P. | 3,182,527 4.500% | -1,245,858 (-28.13%) | Filing |
| 2024-02-01 4:15 pm Purchase | 2024-01-22 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Venrock Healthcare Capital Partners III, L.P. | 4,428,385 6.600% | 4,428,385 (New Position) | Filing |